JPMorgan Reduces PT on Syndax Pharmaceuticals (SNDX) to $33, Maintains “Overweight” Rating

With important upside potential, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) secures a spot connected our database of the best small-cap biotech stocks to bargain according to analysts.

On November 12, 2025, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) saw JPMorgan trim its terms people from $40 to $33, portion reiterating its “Overweight” rating. The terms people accommodation reflects the concern firm’s revisions to its models successful the SMID-cap biotechnology group, arsenic reported by The Fly.

Meanwhile, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) reported Q3 results connected November 3, 2025. The 4th saw a 21% summation successful full gross to $45.9 million, reflecting beardown uptake of its pb therapies. In particular, Revuforj was included successful NCCN guidelines and received FDA support for a broader diligent population, contributing importantly to the company’s sustained growth. Meanwhile, Niktimvo recorded $200 cardinal successful annualized revenue.

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) ended the 4th with $456 cardinal successful currency balances, capable to enactment its ongoing operations and pipeline improvement done to profitability. The company’s nett nonaccomplishment narrowed to $60.7 million, oregon $0.70 per share, compared to $84.1 million, oregon $0.98 per share, successful Q3 2024. Looking ahead, the institution projected full R&D costs of $380 to $385 cardinal for the afloat year.

Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is simply a biopharmaceutical institution that develops and commercializes targeted therapies for uncommon and difficult-to-treat cancers.

While we admit the imaginable of SNDX arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 7 Best Oil and Gas Penny Stocks to Buy According to Analysts and Billionaire Jacob Rothschild’s RIT Capital Partners: 9 Stocks with Huge Upside Potential.

Disclosure: None.